IceCure Medical rises as tumor removal device gets patent in Japan

Icecure Medical

18/01/2023 16:21

** Shares of Israel-based medical device maker Icecure
Medical Ltd  ICCM.O  rise 7.9% to $1.4
    ** Says its device used in cryoablation procedures received
a patent in Japan
    ** Cryoablation uses extremely cold gas to freeze and
destroy abnormal cells or diseased tissue, often used for skin
disorders and cancers
    ** The device, a cryogenic pump, is designed for multiple
and longer duration procedures without the need to refill liquid
nitrogen - ICCM
    ** The patent is effective until 2041 - ICCM
    ** Including session moves, ICCM down ~47% in the past 12
months 
 (Reporting by Mariam E Sunny)
 ((Mariam.ESunny@thomsonreuters.com;))